Pneumonia acquired during hospitalization is called nosocomial pneumonia (NP). Nosocomial pneumonia is divided into two types. Hospital-acquired pneumonia (HAP) refers to hospital-acquired pneumonia, whereas ventilator-associated pneumonia (VAP) refers to ventilator-associated pneumonia. Most clinical literature stresses VAP's importance and associated mortality and morbidity, whereas HAP is fileslib. Hospital Acquired Pneumonia - Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Hospital Acquired Pneumonia (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. Chapter 1: NHSN Overview - January 2022 [PDF - 350 KB] Chapter 2: Identifying Healthcare-associated Infections (HAIs) in NHSN - January 2022 [PDF - 1 MB] Chapter 3: Patient Safety Monthly Reporting Plan - January 2022 [PDF - 300 KB] Chapter 15: CDC Location Labels and Location Descriptions - January 2022 [PDF - 1 MB]
Hospital-acquired (or nosocomial) pneumonia (HAP)is pneumonia that occurs 48 hours or more after admission and did not appear to be incubating at the time of admission. Ventilator-associated pneumonia (VAP)is a type of HAP that develops more than 48 hours after endotracheal intubation. To continue reading this article, you must log in.
Hospital-Acquired Conditions (HACs) are conditions that a patient develops while in the hospital being treated for something else. These conditions cause harm to patients. Hospitals and healthcare providers are focused on reducing specific HACs that occur frequently, can cause significant harm, and are often preventable based on existing evidence.